Scholars Central

Conference abstractPublished 7 Dec 2017

Gene expression profiling reveals novel candidate genetic biomarkers of ovarian carcinoma prognosis and metastasis

Authors: Radka Vaclavikova, Katerina Elsnerova, Marie Ehrlichova, Lukas Rob, Martin Hruda, Petr Skapa, Alena Bartakova, Jiri Bouda, Pavel Soucek

National Institute of Public Health, Czech Republic; Vinohrady University Hospital, Czech Republic; Motol University Hospital, Czech Republic; University Hospital in Pilsen- Charles University, Czech Republic; Charles University, Czech Republic

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Epithelial ovarian cancer (EOC) has the highest mortality among gynecological carcinomas. Given the diversity in responses to the therapy, there is a need for identification of reliable biomarkers of prognosis, progression and prediction of EOC therapy outcome. The aim of our study was (i) to explore differences in expression of 94-gene panel connected to drug transport (ABC, SLC transporters), metabolism and cell cycle regulation in a set of primary EOC tissues (n=60), intraperitoneal metastases (n=29) and control ovarian tissues (n=14) as well as in a validation set of EOCs (n=57) using quantitative real-time PCR; (ii) to investigate associations of gene expression level with prognosis, development of metastasis and progression-free survival of EOC patients. Different gene expression profiles were found in ovarian carcinomas when compared with controls. Expression of ABCA7 significantly increased and that of ESR2 decreased in the order control ovarian tissues - primary EOCs âÂ?Â? EOC metastases. The most important associations between gene expression and clinicopathological data were found for membrane transporters (ABCA2/9/10, ABCG2, SLC16A14) and cell cycle regulators (PLK1, CIT, PRC1). Transporters from the ABCA family, ABCG2 and ESR2 are involved mainly in lipid metabolism, membrane transport and cell proliferation. These processes are thus probably important for EOC progression. In conclusion, we have proposed novel genetic biomarkers of ovarian carcinoma prognosis and progression potentially useful as therapeutic targets.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Proteomics & Bioinformatics
  • SubjectBiochemistry & Biotechnology
  • BylineArticles whose byline prints “Radka Vaclavikova”
  • BylineArticles whose byline prints “Katerina Elsnerova”
  • BylineArticles whose byline prints “Marie Ehrlichova”
  • BylineArticles whose byline prints “Lukas Rob”
  • BylineArticles whose byline prints “Martin Hruda”
  • BylineArticles whose byline prints “Petr Skapa”
  • BylineArticles whose byline prints “Alena Bartakova”
  • BylineArticles whose byline prints “Jiri Bouda”